Fc-silent anti-CD40 antibody prolongs allograft survival

被引：0
|
作者：
机构：
来源：
Nature Reviews Nephrology | 2015年 / 11卷 / 9期
关键词：
D O I：
10.1038/nrneph.2015.122
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：504 / 504
相关论文
共 50 条
  • [31] Anti-CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys
    Chen, G.
    Luke, P. P. W.
    Yang, H.
    Visser, L.
    Sun, H.
    Garcia, B.
    Qian, H.
    Xiang, Y.
    Huang, X.
    Liu, W.
    Senaldi, G.
    Schneider, A.
    Poppema, S.
    Wang, H.
    Jevnikar, A. M.
    Zhong, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (01) : 27 - 37
  • [32] Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model
    Jensen, JN
    Tung, THH
    Mackinnon, SE
    Brenner, MJ
    Hunter, DA
    MICROSURGERY, 2004, 24 (04) : 309 - 315
  • [33] Selective FcγR engagement by human agonistic anti-CD40 antibodies
    Ellmark, Peter
    Mangsbo, Sara M.
    Lindstedt, Malin
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S839 - S841
  • [34] Anti-CD122+Costimulation Blockade Prolongs Allograft Survival
    Mathews, D.
    Higginbotham, L.
    Dong, Y.
    Breeden, C.
    Larsen, C.
    Tso, J.
    Adams, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [35] Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity
    Knorr, David A.
    Dahan, Rony
    Ravetch, Jeffrey, V
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (43) : 11048 - 11053
  • [36] B Cell Depletion Is Not Required for Prolongation of Renal Allograft Survival in Non-Human Primates Using a Novel Anti-CD40 Blocking Antibody
    Rush, J.
    Cordoba, F.
    Wieczorek, G.
    Audet, M.
    Schneider, M.
    Patel, D.
    Heusser, C.
    Bruns, C.
    Ulrich, P.
    Slade, A.
    Klupp, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 379 - 380
  • [37] TOXICITY OF AN FC ENGINEERED ANTI-CD40 ANTIBODY IS ABROGATED BY INTRATUMORAL INJECTION AND RESULTS IN DURABLE ANTI-TUMOR IMMUNITY IN PATIENTS
    Knorr, David
    Ravetch, Jeffrey
    D'Andrea, Gabriela
    Vahdat, Linda
    Klebanoff, Christopher
    Robson, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A528 - A528
  • [38] Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra, KG
    Ringers, J
    Sick, EA
    Ramdien-Murli, S
    Kuhn, EM
    Boon, L
    Jonker, M
    TRANSPLANTATION, 2003, 75 (05) : 637 - 643
  • [39] FR255734, a humanized, Fc-silent, anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model
    Raychaudhuri, Siba P.
    Kundu-Raychaudhuri, Smriti
    Tamura, Kouichi
    Masunaga, Taro
    Kubo, Kaori
    Hanaoka, Kaori
    Jiang, Wen-Yue
    Herzenberg, Leonore A.
    Herzenberg, Leonard A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (08) : 1969 - 1976
  • [40] Antagonist anti-CD40 antibody, CHIR-12.12, induces ADCC, inhibits tumor growth, and prolongs survival in a human multiple myeloma xenograft model.
    Long, L
    Tong, X
    Patawaran, M
    Aukerman, SL
    Jallal, B
    Luqman, M
    BLOOD, 2005, 106 (11) : 968A - 968A
12345